Close Menu

Oxford Nanopore

Oxford Nanopore Technologies was founded in 2005 to develop an electronic, single molecule sensing system based on nanopore science. The company now has more than 250 employees from multiple disciplines including nanopore science, molecular biology and applications, informatics, engineering, electronics, manufacturing and commercialization. Oxford Nanopore's instruments — MinIon, PromethIon, and GridIon are adaptable for the analysis of DNA, RNA, proteins, small molecules and other types of molecule.

Oxford Nanopore Facts

 

CEO: Gordon Sanghera

Website: www.nanoporetech.com

Ticker symbol: Privately held

Headquarters: Oxford, UK

Number of employees: 250+

Scientists from Edgewood Chemical Biological Center and Signature Science published the study this week in GigaScience.

At AGBT last week, MinIon users reported de novo genome assembly, human cDNA sequencing, microbial surveillance, and other projects.

At the AGBT meeting this week, talks will feature real-time surveillance approaches, cDNA sequencing, and de novo genome assembly using MinIon data.

Researchers in Canada and the UK have used data from the Oxford Nanopore MinIon alone to assemble a bacterial genome into a single contig.

MinIon

The researchers concluded that the technology "holds promise for clinical applications."

CSHL scientists described the work in a paper published online earlier this month and in a presentation this week at the annual Plant and Animal Genomes conference.

The team also assessed the performance of the MinIon and how it compares to other platforms.

NEW YORK (GenomeWeb) – Oxford Nanopore Technologies is working on a high-throughput nanopore sequencing platform called PromethIon, along with updates and new applications for the MinIon, according to a company official.

NEW YORK (GenomeWeb) – Early access users of Oxford Nanopore Technologies' MinIon sequencer and their collaborators have used nanopore data they generated to assemble a yeast genome de novo from error-corrected reads, to generate a hybrid de novo assembly of a bacterial genome,

This article, originally published Sept. 4, has been updated with comments from other MinIon early access users.

Pages

23andMe has a holiday popup shop at a mall and could open additional stores, Bloomberg reports.

By studying koalas and a retrovirus that infects them, researchers may have uncovered a new sort of 'immune response' that occurs at the genomic level, Agence France Presse reports.

NPR reports that the first person in the US given a gene editing-based therapy for a genetic disorder is heading home.

In Science this week: ancient genomes reveal social inequality within individual households, new method for quantifying genetic variation in gene dosage, and more.